Rakuten Medical’s Post

Preparing for EUROSPINE, the Spine Society of Europe 2024, DKOU_Berlin 2024 or orther #medicaldevice conferences, and need some additional hands 🤲? Let's discuss how we can assist! BAAT Medical #MedTechInnovation #HealthcareHeroes #TechInMedicine #MedicalTechnology #MedTechExperts #FutureOfHealthcare #MedicalInnovators #MedTechLeaders #HealthcareRevolution

🌟 Breaking Barriers in Healthcare: Our RSNA 2023 Recap 🌟 RSNA 2023 brought together the forefront of innovation and transformative technologies in the healthcare industry to showcase and discuss the future of radiology and imaging technology. This year, the spotlight was on the groundbreaking advancements in remote scanning solutions, sparking vital discussions on the potential to revolutionize the future of the healthcare industry. 🏥💻 Last week, IONIC Health was the sole Brazilian company exhibiting at the event. Together with GE HealthCare, we unveiled an unprecedented collaboration to deliver a multi-vendor, multi-modality remote scanning solution, shattering barriers in healthcare accessibility. nCommand Lite, currently pending 510(k) approval at the FDA, was prominently featured at GE HealthCare’s Digital Solutions booth, among 40 noteworthy innovations announced at RSNA. nCommand Lite is a truly agnostic solution, and we are eager to see this Brazilian technology make a significant impact on a global scale. #RSNA2023 #HealthcareInnovation To all our partners and employees, thank you for being an integral part of this remarkable journey! 🌐🏥 Note: nCommand Lite is 510(K) pending at FDA. Not available for sale in the U.S. Availability in other markets is subject to local regulatory approvals.

At the 2023 MEDICA exhibition, Medical Expo interviewed YHLO and featured YHLO's flagship product, the iFlash 3000 chemiluminescence analyzer. Medical Expo, known for its comprehensive coverage of cutting-edge advancements in the medical industry, serves as a prominent platform that showcases innovative technologies, products, and companies within the healthcare sector. The insightful interview with YHLO at MEDICA highlighted the significance of the iFlash 3000 in advancing diagnostic capabilities and its role as a standout solution in the field of chemiluminescence analysis. #YHLO#iFlash#CLIA

Interoperability was the word of the day at our recent Medtech webinar. 🤓 67% of participants chose it as the biggest challenge facing the evolution of medical devices. Take a deeper look at this and other core challenges by watching back what was an insightful discussion with William Betten (S3 Connected Health), AJ Shah, MD, MPH (Abbott), and John Rondoni (Inspire Medical Systems). Check out the link, watch it back whenever it suits you, and learn from experts in the field 👉 https://hubs.li/Q02ywnxq0

Today, at #ADLM2024, researchers from the UC San Diego School of Medicine will present the latest evidence from a recent evaluation of Truvian’s multi-modal #BloodTesting platform. 🩸 Their independent study, titled “Advancing Point-of-Care Testing: Independent Evaluation of the Truvian Platform,” focused on comparing the performance of Truvian's blood testing device to FDA-cleared devices found in central laboratories. 🔬 Findings show the accuracy of Truvian’s device is highly comparable to centralized testing and demonstrates a high degree of reliability. They also support a growing body of evidence that the future of routine blood testing will be defined by automated, benchtop systems that provide decentralized diagnostics anywhere you go. 🌐 Stop by and learn more about Truvian and see a demo at the ADLM Expo, Booth #3055. See the poster presented by UC San Diego School of Medicine from 1:30-2:30PM at Poster #A-323. 📍 More information about the independent study 👇 https://lnkd.in/gCgWkeXf #Innovation #Healthcare #Diagnostics

Spotlight on TECHNOPARK® Zürich resident STIMIT AG on “10 vor 10” at SRF - Schweizer Radio und Fernsehen 📺 The Medtech designs a non-invasive procedure to preserve the diaphragmatic muscles of ventilated patients. Stimit’s product uses a special headset to generate targeted electromagnetic fields, stimulating the diaphragm via the phrenic nerve to prevent tissue atrophy. Stimit’s co-founder and CEO Ronja Müller-Bruhn is giving insights on the challenges surrounding the approval of medical devices in Europe and Switzerland. The TV report explores how access to innovative medical devices is becoming increasingly difficult for patients in Europe, while Switzerland is working on finding smart ways to navigate these challenges. #technopark_zh #Health #medicine #fda #mdr #medtech #MedicalDeviceRegulation #tv #10vor10 #intensivecare #smarthealth #patientcare

👨⚕️ Today Jari Martelin had the opportunity to speak at the Finnish Medical Convention (Lääkäripäivät 2024) invited by Terveysteknologia ry - Healthtech Finland ⭐️ The topic of the presentation was ”The possibilities of rapid molecular tests at the doctor's office”. 💡 What do you think is the main benefit of having the test done during a doctor's appointment? #Uniogen #diagnostics #infectiousdiseases #moleculardiagnostics #finnishmedicalconvention #lääkäripäivät

Shout out to any companies developing products that help address need for #patientmonitoring or #hospitalathome - particularly in the #cardiovascular space (or for other overlapping chronic conditions)- apply to this #HRX #pitchcompetition #productdevelopment #medtech #digitalhealth #AI #sunriselabs

Back from Berlin after a very interesting time at #EHRA. It was great to catch up and meet with so many people within the MedTech industry in person. Many in the Medtech AF space are pointing out that the 1-year clinical efficacy of PFA is only analogous to hot or cold energy, and that results at this stage are rather disappointing. The question arises - is PFA the holy grail? Despite disappointing clinical efficacy , the increase in speed, more patients being treated, and procedural safety seems to be enough for physicians to keep the mania around PFA alive and well, and the focus of MedTech companies continues to be to create PFA tools. Clearly, the industry is moving towards a non-thermal, tissue-selective, catheter-based PFA atrial fibrillation ablation. Exciting times lie ahead as the industry continues to explore new avenues for better patient outcomes.

Interesting new IOL Interesting and promising new optic concept